PURPOSE: To obtain an 1 methane sulfonic acid salt.1 hydrate exhibiting high solubility to water without exhibiting hygroscopicity and having high stability in an aqueous solution useful as a remedy for hypertension, stenocardia or bronchial asthma, etc.
CONSTITUTION: This compound is expressed by the formula, e.g., trans-N-(1H- pyrazolo[3-4-b]pyridine-4-yl)-4-guanidinomethyl cyclohexane carboxamide.1 methane sulfonic acid salt.1 hydrate. The compound of the formula is obtained by dissolving trans-N-(1H-pyrazolo[3,4-b]pyridine-4-yl)-4-guanidinomethyl cyclohexane carboxamide into a solvent such as methanol, adding a solution containing 1-1.5eq. of methanesulfonic acid in water or methanol, etc., stirring or holding and recrystallizing from a mixed solvent such as water-methanol without contamination of an organic solvent in high purity. The compound is useful as an inhalant, an injection or ophthalmic solutions, etc., and a dose is preferably 0.1-100mg/1 day.
HARADA KYO
KAWAHARA TOSHIO
SATO HIROYUKI
OBATA MINORU
Next Patent: NEW SUBSTANCE STYLOGUANIDINE AND ITS DERIVATIVE